David H. Mason
Chief Tech/Sci/R&D Officer at MIMEDX GROUP, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William Hulse | M | 50 | 5 years | |
| K. Newton | M | 61 | 5 years | |
| William Hawkins | M | 70 | 4 years | |
| Michael Giuliani | M | 69 | 4 years | |
| Scott M. Turner | M | 58 | 8 years | |
| Phyllis Gardner | M | 73 | 3 years | |
| Douglas Rice | M | 58 | 1 years | |
| Cato Laurencin | M | 65 | - | |
| Joe Capper | M | 60 | 1 years | |
| Martin Sutter | M | 68 | 4 years | |
| James Bierman | M | 71 | 5 years | |
| M. Wilsey | M | 71 | 5 years | |
| Rebeccah J. Covert Brown | M | - | 19 years | |
| Ricci Whitlow | F | 55 | 1 years | |
| Mark P. Graves | M | 59 | 6 years | |
| Kate Surdez | F | - | 2 years | |
| Dirk Stevens | M | - | 3 years | |
| Matthew Notarianni | M | - | 2 years | |
| John R. Harper | M | - | 3 years | |
| Kim Moller | F | - | 4 years | |
| Eric Smith | M | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Pete Petit | M | 84 | 9 years | |
| Michael J. Senken | M | 65 | 8 years | |
| William Charles Taylor | M | 55 | 9 years | |
| Homi Shamir | M | 70 | 8 years | |
| Marion Snyder | F | - | 9 years | |
| Charles Robert Evans | M | 77 | 8 years | |
| Doron Pinhas Birger | M | 72 | 14 years | |
| Thomas Looby | M | 52 | 8 years | |
| Alexandra O. Haden | F | 49 | 6 years | |
| Peter Carlson | M | 60 | 4 years | |
| Ed Borkowski | M | 64 | 2 years | |
| Timothy Wright | M | 66 | 3 years | |
| Neil S. Yeston | M | 81 | 8 years | |
| Luis Aguilar | M | 70 | 2 years | |
| John D. Harris | M | - | 2 years | |
| Bruce Hack | M | 75 | 10 years | |
| John E. Cranston | M | - | - | |
| Joseph G. Bleser | M | 78 | 10 years | |
| Robert Stein | M | 73 | 3 years | |
| Roberta L. McCaw | F | 68 | 6 years | |
| J. Terry Dewberry | M | 80 | 11 years | |
| Richard Barry | M | 65 | 1 years | |
| Larry Papasan | M | 84 | 11 years | |
| Thomas Senderovitz | M | 57 |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | 4 years |
| Christopher Rowland | M | 62 | 3 years | |
| Donald E. Fetterolf | M | - | 9 years | |
| Stan Micek | M | - | 3 years | |
| Marlene M. DeSimone | F | - | 5 years | |
| Conan S. Young | M | - | 2 years | |
| Ravit Ram | M | 50 | 9 years | |
| Gloria Matthews | M | - | 2 years | |
| William Phelan | M | 53 | 5 years | |
| Michael W. Carlton | M | - | 9 years | |
| Luc Missorten | M | 69 |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | 3 years |
| Dee Athwal | M | - |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | 8 years |
| Stanley Stern | M | 67 | 2 years | |
| Christopher M. Cashman | M | 56 | 4 years | |
| Srdjan Stankovic | M | 67 |
UCB Pharma, Inc.
UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | 6 years |
| Kevin V. Rubey | M | 66 | 12 years | |
| I. Mark Landy | M | 55 | 3 years | |
| Yuval Yanai | M | 71 | 9 years | |
| Janet Rose Christensen | F | - | - | |
| Arie Mientkavich | M | 81 | 7 years | |
| Brent Miller | M | - | 5 years | |
| Robert P. Borchert | M | - | - | |
| John W. Fara | M | 81 | 9 years | |
| Thomas J. Koob | M | 74 | 14 years | |
| Chuck Koob | M | 79 | 12 years | |
| David James Coles | M | 59 | 1 years | |
| Jeffrey White | M | 70 | - | |
| Rohit Kashyap | M | 53 | 3 years | |
| John J. Howarth | M | - | 2 years | |
| Ari Bronshtein | M | 54 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 64 | 86.49% |
| Israel | 10 | 13.51% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David H. Mason
- Personal Network
